{"count": 12, "results": [{"_id": "33915857", "pmid": 33915857, "pmcid": "PMC8066143", "title": "Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats", "journal": "Pharmaceuticals (Basel)", "authors": ["Zemgulyte G", "Tanaka S", "Hide I", "Sakai N", "Pampuscenko K", "Borutaite V", "Rastenyte D"], "date": "2021-04-01T00:00:00Z", "doi": "10.3390/ph14040312", "meta_date_publication": "2021 Apr 1", "meta_volume": "14", "meta_issue": "4", "meta_pages": "", "score": 50256.78, "text_hl": "Growing evidence suggests that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment also exerts neuroprotective effects against @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@-induced @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@brain damage@@@. ", "citations": {"NLM": "Zemgulyte G, Tanaka S, Hide I, Sakai N, Pampuscenko K, Borutaite V, Rastenyte D. Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats Pharmaceuticals (Basel). 2021 Apr 1;14(4):. PMID: 33915857", "BibTeX": "@article{33915857, title={Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats}, author={Zemgulyte G and Tanaka S and Hide I and Sakai N and Pampuscenko K and Borutaite V and Rastenyte D}, journal={Pharmaceuticals (Basel)}, volume={14}, number={4}}"}}, {"_id": "33197442", "pmid": 33197442, "title": "Metformin ameliorates brain damage caused by cardiopulmonary resuscitation via targeting endoplasmic reticulum stress-related proteins GRP78 and XBP1.", "journal": "Eur J Pharmacol", "authors": ["Chuan L", "Huang X", "Fan C", "Wen S", "Yang X", "Wang J", "Ren J", "Ru J", "Ding L"], "date": "2021-01-15T00:00:00Z", "doi": "10.1016/j.ejphar.2020.173716", "meta_date_publication": "2021 Jan 15", "meta_volume": "891", "meta_issue": "", "meta_pages": "173716", "score": 50256.383, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@brain damage@@@ caused by cardiopulmonary resuscitation via targeting endoplasmic reticulum stress-related proteins @GENE_HSPA5 @GENE_25617 @@@GRP78@@@ and @GENE_XBP1 @GENE_289754 @@@XBP1@@@.", "citations": {"NLM": "Chuan L, Huang X, Fan C, Wen S, Yang X, Wang J, Ren J, Ru J, Ding L. Metformin ameliorates brain damage caused by cardiopulmonary resuscitation via targeting endoplasmic reticulum stress-related proteins GRP78 and XBP1. Eur J Pharmacol. 2021 Jan 15;891():173716. PMID: 33197442", "BibTeX": "@article{33197442, title={Metformin ameliorates brain damage caused by cardiopulmonary resuscitation via targeting endoplasmic reticulum stress-related proteins GRP78 and XBP1.}, author={Chuan L and Huang X and Fan C and Wen S and Yang X and Wang J and Ren J and Ru J and Ding L}, journal={Eur J Pharmacol}, volume={891}, pages={173716}}"}}, {"_id": "35394702", "pmid": 35394702, "title": "Metformin-mediated mitochondrial protection post-cardiac arrest improves EEG activity and confers neuroprotection and survival benefit.", "journal": "FASEB J", "authors": ["Shoaib M", "Choudhary RC", "Chillale RK", "Kim N", "Miyara SJ", "Haque S", "Yin T", "Frankfurt M", "Molmenti EP", "Zanos S", "Kim J", "Becker LB"], "date": "2022-05-01T00:00:00Z", "doi": "10.1096/fj.202200121R", "meta_date_publication": "2022 May", "meta_volume": "36", "meta_issue": "5", "meta_pages": "e22307", "score": 50252.04, "text_hl": "Overall, as an effective and safe drug, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has the potential to be an easily translatable intervention for improving survival and preventing @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@brain damage@@@ after @DISEASE_Heart_Arrest @DISEASE_MESH:D006323 @@@CA@@@.", "citations": {"NLM": "Shoaib M, Choudhary RC, Chillale RK, Kim N, Miyara SJ, Haque S, Yin T, Frankfurt M, Molmenti EP, Zanos S, Kim J, Becker LB. Metformin-mediated mitochondrial protection post-cardiac arrest improves EEG activity and confers neuroprotection and survival benefit. FASEB J. 2022 May;36(5):e22307. PMID: 35394702", "BibTeX": "@article{35394702, title={Metformin-mediated mitochondrial protection post-cardiac arrest improves EEG activity and confers neuroprotection and survival benefit.}, author={Shoaib M and Choudhary RC and Chillale RK and Kim N and Miyara SJ and Haque S and Yin T and Frankfurt M and Molmenti EP and Zanos S and Kim J and Becker LB}, journal={FASEB J}, volume={36}, number={5}, pages={e22307}}"}}, {"_id": "32750367", "pmid": 32750367, "title": "Acute administration of metformin prior to cardiac ischemia/reperfusion injury protects brain injury.", "journal": "Eur J Pharmacol", "authors": ["Leech T", "Apaijai N", "Palee S", "Higgins LA", "Maneechote C", "Chattipakorn N", "Chattipakorn SC"], "date": "2020-10-15T00:00:00Z", "doi": "10.1016/j.ejphar.2020.173418", "meta_date_publication": "2020 Oct 15", "meta_volume": "885", "meta_issue": "", "meta_pages": "173418", "score": 50249.793, "text_hl": "In summary, pre-treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ offers neuroprotection against the @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@brain damages@@@ caused by @DISEASE_Reperfusion_Injury @DISEASE_MESH:D015427 @@@cardiac I/R injury@@@.", "citations": {"NLM": "Leech T, Apaijai N, Palee S, Higgins LA, Maneechote C, Chattipakorn N, Chattipakorn SC. Acute administration of metformin prior to cardiac ischemia/reperfusion injury protects brain injury. Eur J Pharmacol. 2020 Oct 15;885():173418. PMID: 32750367", "BibTeX": "@article{32750367, title={Acute administration of metformin prior to cardiac ischemia/reperfusion injury protects brain injury.}, author={Leech T and Apaijai N and Palee S and Higgins LA and Maneechote C and Chattipakorn N and Chattipakorn SC}, journal={Eur J Pharmacol}, volume={885}, pages={173418}}"}}, {"_id": "33860456", "pmid": 33860456, "title": "Brain Boron Level, DNA Content, and Myeloperoxidase Activity of Metformin-Treated Rats in Diabetes and Prostate Cancer Model.", "journal": "Biol Trace Elem Res", "authors": ["Ozel AB", "Dagsuyu E", "Aydın PK", "Bugan I", "Bulan OK", "Yanardag R", "Yarat A"], "date": "2022-03-01T00:00:00Z", "doi": "10.1007/s12011-021-02708-z", "meta_date_publication": "2022 Mar", "meta_volume": "200", "meta_issue": "3", "meta_pages": "1164-1170", "score": 50248.16, "text_hl": "In this study, the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @CHEMICAL_Boron @CHEMICAL_MESH:D001895 @@@boron@@@ levels and oxidative @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@brain damage@@@ in @SPECIES_10116 @@@rats@@@ due to @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@ was investigated for the first time. ", "citations": {"NLM": "Ozel AB, Dagsuyu E, Aydın PK, Bugan I, Bulan OK, Yanardag R, Yarat A. Brain Boron Level, DNA Content, and Myeloperoxidase Activity of Metformin-Treated Rats in Diabetes and Prostate Cancer Model. Biol Trace Elem Res. 2022 Mar;200(3):1164-1170. PMID: 33860456", "BibTeX": "@article{33860456, title={Brain Boron Level, DNA Content, and Myeloperoxidase Activity of Metformin-Treated Rats in Diabetes and Prostate Cancer Model.}, author={Ozel AB and Dagsuyu E and Aydın PK and Bugan I and Bulan OK and Yanardag R and Yarat A}, journal={Biol Trace Elem Res}, volume={200}, number={3}, pages={1164-1170}}"}}, {"_id": "32990500", "pmid": 32990500, "title": "Metformin prevents brain injury after cardiopulmonary resuscitation by inhibiting the endoplasmic reticulum stress response and activating AMPK-mediated autophagy.", "journal": "Scott Med J", "authors": ["Chuan L", "Zhang L", "Fu H", "Yang Y", "Wang Q", "Jiang X", "Li Z", "Ni K", "Ding L"], "date": "2021-02-01T00:00:00Z", "doi": "10.1177/0036933020961543", "meta_date_publication": "2021 Feb", "meta_volume": "66", "meta_issue": "1", "meta_pages": "16-22", "score": 50246.363, "text_hl": "This effect is closely related to the activation of @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@-induced autophagy and inhibition of the ER stress response. Long-term use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can reduce @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@brain damage@@@ following @DISEASE_Heart_Arrest @DISEASE_MESH:D006323 @@@CA@@@/CPR.", "citations": {"NLM": "Chuan L, Zhang L, Fu H, Yang Y, Wang Q, Jiang X, Li Z, Ni K, Ding L. Metformin prevents brain injury after cardiopulmonary resuscitation by inhibiting the endoplasmic reticulum stress response and activating AMPK-mediated autophagy. Scott Med J. 2021 Feb;66(1):16-22. PMID: 32990500", "BibTeX": "@article{32990500, title={Metformin prevents brain injury after cardiopulmonary resuscitation by inhibiting the endoplasmic reticulum stress response and activating AMPK-mediated autophagy.}, author={Chuan L and Zhang L and Fu H and Yang Y and Wang Q and Jiang X and Li Z and Ni K and Ding L}, journal={Scott Med J}, volume={66}, number={1}, pages={16-22}}"}}, {"_id": "32621159", "pmid": 32621159, "title": "Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway.", "journal": "Metab Brain Dis", "authors": ["Rahimi S", "Ferdowsi A", "Siahposht-Khachaki A"], "date": "2020-10-01T00:00:00Z", "doi": "10.1007/s11011-020-00594-3", "meta_date_publication": "2020 Oct", "meta_volume": "35", "meta_issue": "7", "meta_pages": "1135-1144", "score": 50241.7, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is an activator of @GENE_PRKAA2 @GENE_78975 @@@AMP-activated protein kinase@@@ (@GENE_PRKAA2 @GENE_78975 @@@AMPK@@@). ", "citations": {"NLM": "Rahimi S, Ferdowsi A, Siahposht-Khachaki A. Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway. Metab Brain Dis. 2020 Oct;35(7):1135-1144. PMID: 32621159", "BibTeX": "@article{32621159, title={Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway.}, author={Rahimi S and Ferdowsi A and Siahposht-Khachaki A}, journal={Metab Brain Dis}, volume={35}, number={7}, pages={1135-1144}}"}}, {"_id": "27018597", "pmid": 27018597, "pmcid": "PMC4809545", "title": "Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice", "journal": "PLoS One", "authors": ["Zhou W", "Kavelaars A", "Heijnen CJ"], "date": "2016-03-28T00:00:00Z", "doi": "10.1371/journal.pone.0151890", "meta_date_publication": "2016", "meta_volume": "11", "meta_issue": "3", "meta_pages": "e0151890", "score": 50065.86, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Prevents @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@Cisplatin@@@-Induced @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@Cognitive Impairment@@@ and @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@Brain Damage@@@ in Mice", "citations": {"NLM": "Zhou W, Kavelaars A, Heijnen CJ. Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice PLoS One. 2016;11(3):e0151890. PMID: 27018597", "BibTeX": "@article{27018597, title={Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice}, author={Zhou W and Kavelaars A and Heijnen CJ}, journal={PLoS One}, volume={11}, number={3}, pages={e0151890}}"}}, {"_id": "29228667", "pmid": 29228667, "pmcid": "PMC5716707", "title": "Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway", "journal": "Oncotarget", "authors": ["Tang G", "Yang H", "Chen J", "Shi M", "Ge L", "Ge X", "Zhu G"], "date": "2017-08-10T00:00:00Z", "doi": "10.18632/oncotarget.20105", "meta_date_publication": "2017 Nov 17", "meta_volume": "8", "meta_issue": "58", "meta_pages": "97977-97989", "score": 50050.95, "text_hl": "...In summary, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment alleviates @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@brain damage@@@ after @DISEASE_Sepsis @DISEASE_MESH:D018805 @@@sepsis@@@. ", "citations": {"NLM": "Tang G, Yang H, Chen J, Shi M, Ge L, Ge X, Zhu G. Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway Oncotarget. 2017 Nov 17;8(58):97977-97989. PMID: 29228667", "BibTeX": "@article{29228667, title={Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway}, author={Tang G and Yang H and Chen J and Shi M and Ge L and Ge X and Zhu G}, journal={Oncotarget}, volume={8}, number={58}, pages={97977-97989}}"}}, {"_id": "28017679", "pmid": 28017679, "title": "Metformin protects the brain against ischemia/reperfusion injury through PI3K/Akt1/JNK3 signaling pathways in rats.", "journal": "Physiol Behav", "authors": ["Ge XH", "Zhu GJ", "Geng DQ", "Zhang HZ", "He JM", "Guo AZ", "Ma LL", "Yu DH"], "date": "2017-03-01T00:00:00Z", "doi": "10.1016/j.physbeh.2016.12.021", "meta_date_publication": "2017 Mar 1", "meta_volume": "170", "meta_issue": "", "meta_pages": "115-123", "score": 50050.76, "text_hl": "...Although @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, a first-line antidiabetic drug, can ameliorate @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@/reperfusion (I/R) induced @<m>DISEASE_Brain_Damage_Chronic</m> @DISEASE_MESH:D001925 @@@brain damage@@@, but how @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ benefits injured hippocampus and the mechanisms are still largely unknown. ", "citations": {"NLM": "Ge XH, Zhu GJ, Geng DQ, Zhang HZ, He JM, Guo AZ, Ma LL, Yu DH. Metformin protects the brain against ischemia/reperfusion injury through PI3K/Akt1/JNK3 signaling pathways in rats. Physiol Behav. 2017 Mar 1;170():115-123. PMID: 28017679", "BibTeX": "@article{28017679, title={Metformin protects the brain against ischemia/reperfusion injury through PI3K/Akt1/JNK3 signaling pathways in rats.}, author={Ge XH and Zhu GJ and Geng DQ and Zhang HZ and He JM and Guo AZ and Ma LL and Yu DH}, journal={Physiol Behav}, volume={170}, pages={115-123}}"}}]}